The course of treatment aims to correct the underlying abnormality, with the goal of optimizing physiologic conditions for conception in vivo:
couples use their awareness of ovulation biomarkers (mucus) to time acts of intercourse to maximize chances of conception.
induction or stimulation of ovulation;
medications to enhance cervical mucus production, including vitamin B6, guaifenesin (fluidify secretions), or one of several antibiotics;
and hormonal supplementation in the luteal phase.
Doses of all medications are adjusted according to the response of biomarkers (mucus, bleedings, BBT) and serum levels of estrogen and progesterone measured in the midluteal phase.
Concurrently, couples use their awareness of ovulation biomarkers to time acts of intercourse to maximize chances of conception.
Ongoing evaluation and support during pregnancy often includes supplementation with human-identical progesterone, based on periodic measurement of progesterone levels, in an effort to reduce the risk of adverse pregnancy outcomes.
From Stanford et al J Am Board Fam Med 2008;21:375–384, modified

Comprehensive management of infertility of a couple: conjugal life, sexuality, psychological care

Medical treatment : drugs without direct endocrinologic activity

Medical treatment of ovarian and target organ dysfunction: generality

Medical treatment of ovarian and target organ dysfunction: luteal phase support (during the menstrual cycle or during the pregnancy)

Medical treatment of ovarian and target organ dysfunction: other than luteal phase support

Surgical treatment and Interventional imaging of female infertility

Treatment of female infertility: Dietetic, Food, Plant-based medication

Treatment of female infertility: physical activity

Treatment of male infertility

Treatment of PCOS

Treatments for the premenstrual syndrome